A preliminary new review determined a potential connection among semaglutide plus a unusual eye disease that causes blindness.As a consequence of protection and copyright medication problems, the FDA endorses that men and women only invest in semaglutide medications like copyright and Wegovy with a prescription from a licensed healthcare profession